Leclerc S, Eskild W, Guérin S L
Laboratory of Molecular Endocrinology, CHUL Research Center, Ste-Foy, Québec, Canada.
DNA Cell Biol. 1997 Aug;16(8):951-67. doi: 10.1089/dna.1997.16.951.
High levels of expression for the rat growth hormone (rGH) gene are restricted to the somatotroph cells of the anterior pituitary. Previously, we have shown that rGH cell-specific repression results in part from the recognition of negatively acting silencers by a number of nuclear proteins that repress basal promoter activity. Examination of these silencers revealed the presence of binding sites for proteins that belong to the NF1 family of transcription factors. Indeed, proteins from this family were shown to bind the rGH proximal silencer (designated silencer-1) in in vitro assays. Furthermore, this silencer site is capable of repressing chloramphenicol acetyltransferase (CAT) gene expression driven by an heterologous promoter (that of the mouse p12 gene), even in pituitary cells. Recently, we identified in the 5' untranslated region of the gene encoding human cellular retinol binding protein 1 (hCRBP1) a negative regulatory element (Fp1) that also bears an NF1 binding site very similar to that of rGH silencer-1. However, although deletion of Fp1 in the hCRBP1 gene yielded increased CAT activity, pointing toward a negative regulatory function exerted by this element, its insertion upstream of the p12 basal promoter results in an impressive positive stimulation of CAT gene expression. By exploiting NaDodSO4 gel protein fractionation and renaturation, we identified a 40-kD nuclear protein (designated Bp1) present in GH4C1 cells that binds very strongly to rGH silencer-1 but only weakly to hCRBP1 Fp1. Similarly, we also detected a 29-kD nuclear factor (designated Bp2) that recognizes exclusively the Fp1 element as its target site, therefore suggesting that different, but likely related, proteins bind these homologous elements to either activate or repress gene transcription. Although they bind DNA through the recognition of the NF1-like target sequence contained on these elements, competition and supershift experiments in electrophoretic mobility shift assays provided evidence that neither of these proteins belong to the NF1 family.
大鼠生长激素(rGH)基因的高水平表达仅限于垂体前叶的促生长激素细胞。此前,我们已经表明,rGH细胞特异性抑制部分是由于多种核蛋白识别负性作用的沉默子,这些核蛋白会抑制基础启动子活性。对这些沉默子的研究发现了属于转录因子NF1家族的蛋白质的结合位点。事实上,在体外实验中,该家族的蛋白质被证明能与rGH近端沉默子(命名为沉默子-1)结合。此外,即使在垂体细胞中,这个沉默子位点也能够抑制由异源启动子(小鼠p12基因的启动子)驱动的氯霉素乙酰转移酶(CAT)基因的表达。最近,我们在编码人细胞视黄醇结合蛋白1(hCRBP1)的基因的5'非翻译区鉴定出一个负调控元件(Fp1),它也带有一个与rGH沉默子-1非常相似的NF1结合位点。然而,尽管hCRBP1基因中Fp1的缺失导致CAT活性增加,表明该元件发挥负调控功能,但其插入p12基础启动子上游会导致CAT基因表达受到显著的正向刺激。通过利用十二烷基硫酸钠凝胶蛋白分级分离和复性技术,我们在GH4C1细胞中鉴定出一种40-kD的核蛋白(命名为Bp1),它与rGH沉默子-1结合非常紧密,但与hCRBP1 Fp1的结合较弱。同样,我们还检测到一种29-kD的核因子(命名为Bp2),它只将Fp1元件识别为其靶位点,因此表明不同但可能相关的蛋白质结合这些同源元件以激活或抑制基因转录。尽管它们通过识别这些元件上包含的类NF1靶序列来结合DNA,但电泳迁移率变动分析中的竞争和超迁移实验提供了证据,表明这些蛋白质都不属于NF1家族。